Thousands of men battling prostate cancer could be cured with a 'game-changing' HOUR-long operation that uses electrical currents to destroy tumours

 Thousands of men with prostate cancer in the UK could be cured with an hour-long operation, doctors hope. 

The 'game-changing' treatment uses electrical currents to destroy difficult to reach tumours.  

Surgery to remove the prostate or radiotherapy are the options normally offered to men with the disease.

The therapy, called Nanoknife, has been dubbed as 'amazing, simple and quick' after being found to have fewer side effects. 

+1

The 'game-changing' treatment uses electrical currents to destroy difficult to reach tumours. Surgery to remove the prostrate or radiotherapy are the options normally offered to men with the disease

Surgeons at University College London Hospital (UCLH) have already used it to treat prostate cancer patients. 

And medics have called for bigger trials of the procedure, with it already used for liver and pancreatic cancers.

The process – called irreversible electroporation – involves sending electrical pulses into tumours which cut open the membrane of the cells.

This targeted style of treatment increases the level of precision while reducing risks to surrounding organs.

It can take less than an hour and patients don't need to stay in overnight, freeing up valuable time and space in hospitals. 

Prostate cancer will affect one in six men across their lifetime as more than 50,000 cases are found every year.

Diagnoses of the disease fell by almost a quarter during the pandemic.

Professor Mark Emberton, one of the country's leading prostate surgeons, told The Daily Telegraph: 'The beauty of it is that it's such a simple technique to train surgeons in. That makes it a game-changer.' 

'It's an amazing treatment, so quick, and it means we can reach tumours that are beyond where the knife can reach.'

Alistair Grey, the consultant urologist who led the first operations, told The Telegraph: 'What is very exciting about this treatment is its precision in targeting and attacking the cancerous cells without damaging healthy tissue, and maintaining the prostate's important functions.'